Nano-X Imaging (NNOX) Competitors $5.15 +0.16 (+3.21%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$5.16 +0.01 (+0.29%) As of 05/2/2025 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NNOX vs. TNDM, BLFS, FNA, AORT, MDXG, INMD, EYE, ESTA, AXGN, and EMBCShould you be buying Nano-X Imaging stock or one of its competitors? The main competitors of Nano-X Imaging include Tandem Diabetes Care (TNDM), BioLife Solutions (BLFS), Paragon 28 (FNA), Artivion (AORT), MiMedx Group (MDXG), InMode (INMD), National Vision (EYE), Establishment Labs (ESTA), AxoGen (AXGN), and Embecta (EMBC). These companies are all part of the "medical equipment" industry. Nano-X Imaging vs. Tandem Diabetes Care BioLife Solutions Paragon 28 Artivion MiMedx Group InMode National Vision Establishment Labs AxoGen Embecta Tandem Diabetes Care (NASDAQ:TNDM) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, risk, dividends, valuation, institutional ownership, profitability, earnings, analyst recommendations and community ranking. Do analysts rate TNDM or NNOX? Tandem Diabetes Care currently has a consensus price target of $39.81, suggesting a potential upside of 85.35%. Nano-X Imaging has a consensus price target of $12.00, suggesting a potential upside of 133.01%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, analysts clearly believe Nano-X Imaging is more favorable than Tandem Diabetes Care.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tandem Diabetes Care 0 Sell rating(s) 8 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.53Nano-X Imaging 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer TNDM or NNOX? In the previous week, Tandem Diabetes Care had 37 more articles in the media than Nano-X Imaging. MarketBeat recorded 37 mentions for Tandem Diabetes Care and 0 mentions for Nano-X Imaging. Tandem Diabetes Care's average media sentiment score of 0.88 beat Nano-X Imaging's score of 0.00 indicating that Tandem Diabetes Care is being referred to more favorably in the media. Company Overall Sentiment Tandem Diabetes Care Positive Nano-X Imaging Neutral Does the MarketBeat Community prefer TNDM or NNOX? Tandem Diabetes Care received 556 more outperform votes than Nano-X Imaging when rated by MarketBeat users. However, 73.91% of users gave Nano-X Imaging an outperform vote while only 60.89% of users gave Tandem Diabetes Care an outperform vote. CompanyUnderperformOutperformTandem Diabetes CareOutperform Votes59060.89% Underperform Votes37939.11% Nano-X ImagingOutperform Votes3473.91% Underperform Votes1226.09% Do insiders & institutionals believe in TNDM or NNOX? 21.5% of Nano-X Imaging shares are held by institutional investors. 1.9% of Tandem Diabetes Care shares are held by insiders. Comparatively, 7.7% of Nano-X Imaging shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has more risk and volatility, TNDM or NNOX? Tandem Diabetes Care has a beta of 1.52, suggesting that its stock price is 52% more volatile than the S&P 500. Comparatively, Nano-X Imaging has a beta of 2.03, suggesting that its stock price is 103% more volatile than the S&P 500. Is TNDM or NNOX more profitable? Tandem Diabetes Care has a net margin of -14.84% compared to Nano-X Imaging's net margin of -465.38%. Nano-X Imaging's return on equity of -27.63% beat Tandem Diabetes Care's return on equity.Company Net Margins Return on Equity Return on Assets Tandem Diabetes Care-14.84% -44.19% -11.99% Nano-X Imaging -465.38%-27.63%-24.72% Which has preferable earnings and valuation, TNDM or NNOX? Nano-X Imaging has lower revenue, but higher earnings than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTandem Diabetes Care$940.20M1.52-$222.61M-$1.46-14.71Nano-X Imaging$11.28M26.37-$60.78M-$0.90-5.72 SummaryNano-X Imaging beats Tandem Diabetes Care on 11 of the 18 factors compared between the two stocks. Get Nano-X Imaging News Delivered to You Automatically Sign up to receive the latest news and ratings for NNOX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NNOX vs. The Competition Export to ExcelMetricNano-X ImagingX IndustryBusiness SectorNASDAQ ExchangeMarket Cap$297.56M$11.57B$22.31B$8.02BDividend YieldN/A1.92%2.59%4.23%P/E Ratio-6.0616.6931.1718.83Price / Sales26.377.85172.62106.72Price / CashN/A11.9031.5134.62Price / Book1.452.015.604.33Net Income-$60.78M$344.53M$194.12M$247.97M7 Day Performance-1.90%-1.18%2.52%3.16%1 Month Performance10.28%2.18%20.04%8.10%1 Year Performance-44.89%-1.37%30.30%4.99% Nano-X Imaging Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NNOXNano-X Imaging1.7168 of 5 stars$5.15+3.2%$12.00+133.0%-44.3%$297.56M$11.28M-6.06190TNDMTandem Diabetes Care4.6128 of 5 stars$17.49-3.2%$43.81+150.6%-41.2%$1.17B$940.20M-9.102,600Earnings ReportAnalyst ForecastAnalyst RevisionNews CoveragePositive NewsBLFSBioLife Solutions1.5563 of 5 stars$24.51-1.8%$31.17+27.2%+39.2%$1.16B$82.25M-23.03440Upcoming EarningsPositive NewsFNAParagon 281.4233 of 5 stars$13.11+0.1%$14.20+8.4%+34.1%$1.10B$256.18M-17.71343,000High Trading VolumeAORTArtivion3.5692 of 5 stars$23.76-0.3%$31.40+32.2%+13.7%$1.01B$388.54M-1,186.151,300Upcoming EarningsNews CoveragePositive NewsMDXGMiMedx Group3.4109 of 5 stars$6.85-0.9%$12.00+75.3%-15.7%$1.01B$348.88M12.45870Earnings ReportAnalyst UpgradeNews CoverageINMDInMode3.4323 of 5 stars$14.22-12.3%$20.20+42.1%-16.1%$992.89M$394.82M6.07480Earnings ReportAnalyst ForecastOptions VolumeNews CoverageHigh Trading VolumeEYENational Vision1.3253 of 5 stars$12.33+0.2%$14.00+13.6%-25.2%$969.43M$1.82B-61.5214,000Upcoming EarningsNews CoveragePositive NewsESTAEstablishment Labs2.7865 of 5 stars$29.68-1.0%$57.40+93.4%-32.5%$852.54M$166.03M-11.46960Upcoming EarningsNews CoverageAXGNAxoGen2.946 of 5 stars$16.20-1.2%$22.60+39.5%+191.3%$721.21M$187.34M-50.83450Upcoming EarningsPositive NewsEMBCEmbecta4.6043 of 5 stars$12.35+3.9%$20.33+64.7%+24.4%$715.63M$1.11B12.311,900Upcoming EarningsNews CoveragePositive News Related Companies and Tools Related Companies Tandem Diabetes Care Competitors BioLife Solutions Competitors Paragon 28 Competitors Artivion Competitors MiMedx Group Competitors InMode Competitors National Vision Competitors Establishment Labs Competitors AxoGen Competitors Embecta Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NNOX) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nano-X Imaging Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nano-X Imaging With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NNOX Stock Free NNOX Stock Alerts